tradingkey.logo

10X Genomics Inc

TXG
18.540USD
-0.070-0.38%
收盤 02/09, 16:00美東報價延遲15分鐘
1.74B總市值
虧損本益比TTM

10X Genomics Inc

18.540
-0.070-0.38%

關於 10X Genomics Inc 公司

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.

10X Genomics Inc簡介

公司代碼TXG
公司名稱10X Genomics Inc
上市日期Sep 12, 2019
CEOSaxonov (Serge Wilson)
員工數量1306
證券類型Ordinary Share
年結日Sep 12
公司地址6230 Stoneridge Mall Road
城市PLEASANTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94588
電話19254017300
網址https://www.10xgenomics.com/
公司代碼TXG
上市日期Sep 12, 2019
CEOSaxonov (Serge Wilson)

10X Genomics Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.09M
+50000.00%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
369.61K
+15357.00%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+45563.00%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
59.45K
+15357.00%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
36.41K
-8283.00%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
28.62K
+15357.00%
Dr. Shehnaaz Suliman, M.D.
Dr. Shehnaaz Suliman, M.D.
Independent Director
Independent Director
28.62K
+15357.00%
Mr. Alan V. Mateo
Mr. Alan V. Mateo
Independent Director
Independent Director
--
--
Dr. Sarah A. Teichmann
Dr. Sarah A. Teichmann
Independent Director
Independent Director
--
--
Mr. Adam S. Taich
Mr. Adam S. Taich
Chief Financial Officer
Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.09M
+50000.00%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
369.61K
+15357.00%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+45563.00%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
59.45K
+15357.00%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
36.41K
-8283.00%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
28.62K
+15357.00%

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Consumables
127.89M
85.83%
Instruments
12.00M
8.05%
Services
8.13M
5.45%
License and royalty revenue
983.00K
0.66%
地區USD
名稱
營收
佔比
United States
77.25M
51.84%
Europe, the Middle East and Africa
41.62M
27.94%
China
15.19M
10.19%
Asia Pacific
12.32M
8.27%
Americas
2.63M
1.76%
業務
地區
業務USD
名稱
營收
佔比
Consumables
127.89M
85.83%
Instruments
12.00M
8.05%
Services
8.13M
5.45%
License and royalty revenue
983.00K
0.66%

股東統計

更新時間: 11月19日 週三
更新時間: 11月19日 週三
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.16%
ARK Investment Management LLC
10.21%
BlackRock Institutional Trust Company, N.A.
6.68%
Fidelity Management & Research Company LLC
6.19%
Sumitomo Mitsui Trust Bank, Limited
4.72%
其他
61.05%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.16%
ARK Investment Management LLC
10.21%
BlackRock Institutional Trust Company, N.A.
6.68%
Fidelity Management & Research Company LLC
6.19%
Sumitomo Mitsui Trust Bank, Limited
4.72%
其他
61.05%
股東類型
持股股東
佔比
Investment Advisor
52.87%
Investment Advisor/Hedge Fund
27.36%
Hedge Fund
13.85%
Research Firm
6.25%
Bank and Trust
5.11%
Venture Capital
1.88%
Individual Investor
1.84%
Family Office
0.90%
Pension Fund
0.53%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
703
125.95M
108.13%
-14.86M
2025Q3
675
117.21M
102.45%
-24.61M
2025Q2
669
120.42M
108.39%
-15.20M
2025Q1
687
115.67M
104.27%
-8.84M
2024Q4
689
107.08M
98.92%
-12.41M
2024Q3
682
106.90M
100.39%
-9.08M
2024Q2
691
105.36M
99.70%
-5.09M
2024Q1
762
106.36M
101.17%
-3.12M
2023Q4
817
100.80M
96.01%
-9.73M
2023Q3
835
96.86M
93.80%
-12.55M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
13.25M
11.38%
+834.27K
+6.72%
Sep 30, 2025
ARK Investment Management LLC
11.89M
10.21%
-2.00M
-14.43%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
7.78M
6.68%
+194.98K
+2.57%
Sep 30, 2025
Fidelity Management & Research Company LLC
7.21M
6.19%
-430.91K
-5.64%
Sep 30, 2025
Sumitomo Mitsui Trust Bank, Limited
5.38M
4.62%
-636.74K
-10.58%
Sep 30, 2025
Millennium Management LLC
5.44M
4.67%
+2.55M
+88.57%
Sep 30, 2025
Amova Asset Management Co., Ltd.
5.38M
4.62%
+5.38M
--
Sep 30, 2025
Wellington Management Company, LLP
4.29M
3.68%
+2.39M
+126.60%
Sep 30, 2025
Quantinno Capital Management LP
3.49M
3%
+1.26M
+56.37%
Sep 30, 2025
BofA Global Research (US)
3.30M
2.83%
+393.85K
+13.55%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
ARK Genomic Revolution ETF
4.02%
Simplify Health Care ETF
2.89%
Janus Henderson Small Cap Growth Alpha ETF
1.66%
Global X Genomics & Biotechnology ETF
1.56%
ARK Innovation ETF
1.3%
WisdomTree BioRevolution Fund
1.28%
Janus Henderson Small/Mid Cap Growth Alpha ETF
1.17%
Harbor Long-Short Equity ETF
0.61%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.53%
Invesco NASDAQ Future Gen 200 ETF
0.52%
查看更多
ARK Genomic Revolution ETF
佔比4.02%
Simplify Health Care ETF
佔比2.89%
Janus Henderson Small Cap Growth Alpha ETF
佔比1.66%
Global X Genomics & Biotechnology ETF
佔比1.56%
ARK Innovation ETF
佔比1.3%
WisdomTree BioRevolution Fund
佔比1.28%
Janus Henderson Small/Mid Cap Growth Alpha ETF
佔比1.17%
Harbor Long-Short Equity ETF
佔比0.61%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比0.53%
Invesco NASDAQ Future Gen 200 ETF
佔比0.52%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI